Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
应用 MYC 降解筛选确定 KRAS 突变型胰腺癌对 CDK9 抑制剂的敏感性
期刊:Science Signaling
影响因子:
doi:10.1126/scisignal.aav7259
Devon R Blake, Angelina V Vaseva, Richard G Hodge, McKenzie P Kline, Thomas S K Gilbert, Vikas Tyagi, Daowei Huang, Gabrielle C Whiten, Jacob E Larson, Xiaodong Wang, Kenneth H Pearce, Laura E Herring, Lee M Graves, Stephen V Frye, Michael J Emanuele, Adrienne D Cox, Channing J Der